Epidemiological Study of Breast Cancer in Erbil, Kurdistan Region

Authors

  • Sarkawt M. Khoshnaw Rizgary Oncology Center, Erbil Screening and Prevention, Erbil Cancer Control Unit, Erbil Directorate of Health, Erbil, Kurdistan Region, Iraq; School of Medicine, University of Kurdistan Hewlêr, Erbil, Kurdistan Region, Iraq
  • Aryan R. Ganjo Department of Clinical Analysis, College of Pharmacy, Hawler Medical University, Erbil, Kurdistan Region, Iraq; Department of Medical Analysis, Faculty of Applied Science, Tishk International University, Erbil, Iraq
  • Mohammed S. Salih Department of Clinical Analysis, College of Pharmacy, Hawler Medical University, Erbil, Kurdistan Region, Iraq

DOI:

https://doi.org/10.25079/ukhjse.v7n1y2023.pp11-16

Keywords:

Breast Cancer, Epidemiologyv, Hormone Receptor, HER2, Therapeutic Interventions, Erbil

Abstract

Breast cancer is the most diagnosed cancer and the second leading cause of cancer death among women in the world. Compared to some other regions in the world, amount of information available about breast cancer epidemiology in the Kurdistan Region of Iraq is scarce. This study is an attempt to enrich our knowledge about different epidemiological aspects of breast cancer in the region since epidemiological studies contribute quite significantly to the current knowledge of environmental and genetic risk factors and to the current treatment strategies for breast cancer. In addition, studies has shown that the past and ongoing research has a massive implication in improving the outcome of this common disease. This work takes all women diagnosed with breast cancer at Nanakaly Hospital in Erbil, Iraq as sample of the study. Patient characteristics were captured then statistical analysis was performed on these data sets. The majority of patients were found to be city dwellers and about 46% were diagnosed at stage II and 40% at stage III. The vast majority of cases tested positive for hormone receptors but negative for HER2. 

Downloads

Download data is not yet available.

References

Abdulrazzaq, S. A. and Ahmed, N. Y. (2020). Clinicopathological and immunohistochemical correlations of breast carcinoma with vitamin D status in Erbil Governorate, Kurdistan of Iraq. Zanco Journal of Medical Sciences (Zanco J Med Sci), 24, 54-64.
Al-Thoubaity, F. K. (2020). Molecular classification of breast cancer: A retrospective cohort study. Annals of Medicine and Surgery, 49, 44-48.
Amir, A. K., Aamir Jalal, A. M., Ohan Faraj, Y., Heyem Muzahim, F. and Sanaa, S. (2010). The histopathologic pattern of breast cancer in Iraq. The New Iraqi Journal of Medicine 6(3): 59-64
Dunyo, P., Effah, K. and Udofia, E. A. (2018). Factors associated with late presentation of cervical cancer cases at a district hospital: a retrospective study. BMC Public Health, 18, 1-10.
Ghoncheh, M., Pournamdar, Z. and Salehiniya, H. (2016). Incidence and mortality and epidemiology of breast cancer in the world. Asian Pacific journal of cancer prevention, 17, 43-46.
Ibrahim, A. S., Khaled, H. M., Mikhail, N. N., Baraka, H. and Kamel, H. (2014). Cancer incidence in egypt: results of the national population-based cancer registry program. Journal of cancer epidemiology, 2014, 437971. DOI: https://doi.org/10.1155/2014/437971.
Jemal, A., Center, M. M., Desantis, C. and Ward, E. M. (2010). Global Patterns of Cancer Incidence and Mortality Rates and TrendsGlobal Patterns of Cancer. Cancer epidemiology, biomarkers & prevention, 19, 1893-1907.
Jiang, Y., Xie, Q. and Chen, R. (2022). Breast cancer incidence and mortality in relation to hormone replacement therapy use among postmenopausal women: results from a prospective cohort study. Clinical Breast Cancer, 22, 206-213.
Kartal, M., Tezcan, S. and Canda, T. (2013). Diagnosis, treatment characteristics, and survival of women with breast cancer aged 65 and above: a hospital-based retrospective study. BMC women's health, 13, 1-7.
Kunkler, I. H., Williams, L. J., Jack, W. J., Cameron, D. A. and Dixon, J. M. (2015). Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. The lancet oncology, 16, 266-273.
Louwman, W., Vulto, J., Verhoeven, R., Nieuwenhuijzen, G., Coebergh, J. and Voogd, A. (2007). Clinical epidemiology of breast cancer in the elderly. European journal of cancer, 43, 2242-2252.
Łukasiewicz, S., Czeczelewski, M., Forma, A., Baj, J., Sitarz, R. and Stanisławek, A. (2021). Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review. Cancers, 13, 4287.
Mjali, A., Jawad, S. A. and Al-Shammari, H. H. J. (2021). Breast cancer in middle euphrates region of Iraq: risk factors, presenting symptoms and time to medical help-seeking. Asian Pacific Journal of Cancer Care, 6, 243-247.
Sathwara, J. A., Balasubramaniam, G., Bobdey, S. C., Jain, A. and Saoba, S. (2017). Sociodemographic Factors and Late‑stage Diagnosis of Breast Cancer in India: A Hospital‑based Study. Indian Journal of Medical and Paediatric Oncology, 38, 277-281.
Schwartz, A. M., Henson, D. E., Chen, D. and Rajamarthandan, S. (2014). Histologic grade remains a prognostic factor for breast cancer regardless of the number of positive lymph nodes and tumor size: a study of 161 708 cases of breast cancer from the SEER Program. Archives of Pathology and Laboratory Medicine, 138, 1048-1052.
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A. and Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 71, 209-249.
Swinny, C. A., Kagee, A. and Roomaney, R. (2022). Delayed help-seeking for symptomatic breast cancer: reasons for delay among participants receiving treatment at a public healthcare facility in South Africa. South African Journal of Psychology, 52, 87-98.
Vinogradova, Y., Coupland, C. and Hippisley-Cox, J. (2020). Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases. bmj, 371.
Wijeratne, D. T., Gunasekera, S., Booth, C. M., Promod, H., Jalink, M., Jayarajah, U. and Seneviratne, S. (2021). Demographic, tumour, and treatment characteristics of female patients with breast cancer in Sri Lanka; results from a hospital-based cancer registry. BMC cancer, 21, 1-8.
Yip, C., Buccimazza, I., Hartman, M., Deo, S. and Cheung, P. (2015). Improving outcomes in breast cancer for low and middle income countries. World journal of surgery, 39, 686-692.

Downloads

Published

2023-08-28

Issue

Vol. 7 No. 1 (2023): ISSUE 12

Section

Research Articles

License

Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License [CC BY-NC-ND 4.0] that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

How to Cite

Epidemiological Study of Breast Cancer in Erbil, Kurdistan Region. (2023). UKH Journal of Science and Engineering, 7(1), 11-16. https://doi.org/10.25079/ukhjse.v7n1y2023.pp11-16

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>